[
  {
    "ts": null,
    "headline": "Merck (NYSE:MRK) Gains FDA Approval For RSV Treatment, Reports Positive Trial Results",
    "summary": "Merck (NYSE:MRK) experienced a 4% price move over the last month, driven by crucial developments in its product offerings. The FDA approval of ENFLONSIA for RSV prevention and the successful clinical trial results for enlicitide decanoate in treating hyperlipidemia have reinforced Merck's portfolio strength. These medical advancements align with broader market trends, where the S&P 500 and Nasdaq recently reached high levels due to optimism surrounding trade talks between the U.S. and China...",
    "url": "https://finnhub.io/api/news?id=d08d3d16cf96000ef3b14f171656a2a5306464b1ee9759a2d5109db9d245f3c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749577221,
      "headline": "Merck (NYSE:MRK) Gains FDA Approval For RSV Treatment, Reports Positive Trial Results",
      "id": 135170992,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (NYSE:MRK) experienced a 4% price move over the last month, driven by crucial developments in its product offerings. The FDA approval of ENFLONSIA for RSV prevention and the successful clinical trial results for enlicitide decanoate in treating hyperlipidemia have reinforced Merck's portfolio strength. These medical advancements align with broader market trends, where the S&P 500 and Nasdaq recently reached high levels due to optimism surrounding trade talks between the U.S. and China...",
      "url": "https://finnhub.io/api/news?id=d08d3d16cf96000ef3b14f171656a2a5306464b1ee9759a2d5109db9d245f3c1"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Best Case For Option Collars We'll Ever See",
    "summary": "Currently, Merck stock shows potential for another collar setup, with defined risk and reward, though I haven't executed a new trade yet. Read why MRK is a Buy.",
    "url": "https://finnhub.io/api/news?id=2f788caf405013d6aaabdd09176878fbefe59884a4f22195d2ac728173da40f2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749575058,
      "headline": "Merck: Best Case For Option Collars We'll Ever See",
      "id": 135170350,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210931291/image_1210931291.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Currently, Merck stock shows potential for another collar setup, with defined risk and reward, though I haven't executed a new trade yet. Read why MRK is a Buy.",
      "url": "https://finnhub.io/api/news?id=2f788caf405013d6aaabdd09176878fbefe59884a4f22195d2ac728173da40f2"
    }
  },
  {
    "ts": null,
    "headline": "Drug pricing reform talks with US government lack clarity, industry executives say",
    "summary": "Talks with the Trump administrationabout lowering U.S. drug prices have so far not provided clarityon when and how reduced prices will be implemented, topexecutives from Eli Lilly and Merck said at...",
    "url": "https://finnhub.io/api/news?id=63ced8516bbfaa91f0a0c2b78f53454177959516799b22c5d438c3419f1e7626",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749573315,
      "headline": "Drug pricing reform talks with US government lack clarity, industry executives say",
      "id": 135170196,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Talks with the Trump administrationabout lowering U.S. drug prices have so far not provided clarityon when and how reduced prices will be implemented, topexecutives from Eli Lilly and Merck said at...",
      "url": "https://finnhub.io/api/news?id=63ced8516bbfaa91f0a0c2b78f53454177959516799b22c5d438c3419f1e7626"
    }
  },
  {
    "ts": null,
    "headline": "Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants",
    "summary": "MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.",
    "url": "https://finnhub.io/api/news?id=d4f2897a7f9b8a6f04ab9daaa9920c2a9d9daa29c404eda0ce76d8811af0265f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749567000,
      "headline": "Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants",
      "id": 135169849,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.",
      "url": "https://finnhub.io/api/news?id=d4f2897a7f9b8a6f04ab9daaa9920c2a9d9daa29c404eda0ce76d8811af0265f"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript",
    "summary": "Merck &amp; Co., Inc. (NYSE:MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ETCompany ParticipantsDean Y.",
    "url": "https://finnhub.io/api/news?id=adeaf14b14c5e96802c114d0dcfce93dedf0066275e6f81af349521da1893876",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749560167,
      "headline": "Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript",
      "id": 135161796,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck &amp; Co., Inc. (NYSE:MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ETCompany ParticipantsDean Y.",
      "url": "https://finnhub.io/api/news?id=adeaf14b14c5e96802c114d0dcfce93dedf0066275e6f81af349521da1893876"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine stocks muted as investors assess Kennedy's overhaul of key panel",
    "summary": "Shares of global vaccine makers weremixed on Tuesday, as investors assessed U.S. Health SecretaryRobert F. Kennedy Jr.'s surprising decision to fire all 17members of a key expert panel late on...",
    "url": "https://finnhub.io/api/news?id=8f3023f73bf035bdcb10deeb244e9c5f219acd161ab6b11f2298228cf8f1687b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749559693,
      "headline": "Vaccine stocks muted as investors assess Kennedy's overhaul of key panel",
      "id": 135161012,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Shares of global vaccine makers weremixed on Tuesday, as investors assessed U.S. Health SecretaryRobert F. Kennedy Jr.'s surprising decision to fire all 17members of a key expert panel late on...",
      "url": "https://finnhub.io/api/news?id=8f3023f73bf035bdcb10deeb244e9c5f219acd161ab6b11f2298228cf8f1687b"
    }
  },
  {
    "ts": null,
    "headline": "5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen",
    "summary": "Fortune has partnered with Indiggo to measure Return On Leadership, called the ROL100. Read which dividend stocks we recommend from the list.",
    "url": "https://finnhub.io/api/news?id=ab3738e113bcda4ee72d65cbb95f1689283e6dabb69ca10d1bd4dbb1aad2f56e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749559623,
      "headline": "5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen",
      "id": 135161067,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1410966689/image_1410966689.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Fortune has partnered with Indiggo to measure Return On Leadership, called the ROL100. Read which dividend stocks we recommend from the list.",
      "url": "https://finnhub.io/api/news?id=ab3738e113bcda4ee72d65cbb95f1689283e6dabb69ca10d1bd4dbb1aad2f56e"
    }
  },
  {
    "ts": null,
    "headline": "Sec. Kennedy Removes ACIP Members, Big Pharma Is Unfazed - Maybe It Should Be",
    "summary": "Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may mean for the industry.",
    "url": "https://finnhub.io/api/news?id=9f4de29a750144ec715b5a73ee2f6c4e15c7ffadce2ac98e2f9c6bf6b8b1fe65",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749559471,
      "headline": "Sec. Kennedy Removes ACIP Members, Big Pharma Is Unfazed - Maybe It Should Be",
      "id": 135161082,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1039636708/image_1039636708.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may mean for the industry.",
      "url": "https://finnhub.io/api/news?id=9f4de29a750144ec715b5a73ee2f6c4e15c7ffadce2ac98e2f9c6bf6b8b1fe65"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Merck & Co., Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10",
    "summary": "Presenter SpeechChris Shibutani Let's get started. Very excited to welcome the Merck to our next session, Rob Davis, Chairman and CEO; Dean Li, EVP and President of Merck Research Labs. Welcome,",
    "url": "https://finnhub.io/api/news?id=27b2c21355f8b1432ad0c51442fc8223d88fc2b8188e61d4e0c13de1bce87daf",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749555349,
      "headline": "Transcript : Merck & Co., Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10",
      "id": 135155610,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Presenter SpeechChris Shibutani Let's get started. Very excited to welcome the Merck to our next session, Rob Davis, Chairman and CEO; Dean Li, EVP and President of Merck Research Labs. Welcome,",
      "url": "https://finnhub.io/api/news?id=27b2c21355f8b1432ad0c51442fc8223d88fc2b8188e61d4e0c13de1bce87daf"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.",
    "summary": "Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.",
    "url": "https://finnhub.io/api/news?id=79375810e4c60fa0bafd3f7532b069b05f56e9dfe7f2be82c728f1fb6787f82a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749551100,
      "headline": "Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.",
      "id": 135152465,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.",
      "url": "https://finnhub.io/api/news?id=79375810e4c60fa0bafd3f7532b069b05f56e9dfe7f2be82c728f1fb6787f82a"
    }
  },
  {
    "ts": null,
    "headline": "The Highest-Quality Dividend Contenders By Quality Scores",
    "summary": "The Highest-Quality Dividend Contenders By Quality Scores",
    "url": "https://finnhub.io/api/news?id=1a715141ace3b115707a223df8914be7859358185883c42415537be64b013a81",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749546000,
      "headline": "The Highest-Quality Dividend Contenders By Quality Scores",
      "id": 135148116,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=1a715141ace3b115707a223df8914be7859358185883c42415537be64b013a81"
    }
  },
  {
    "ts": null,
    "headline": "Insmed's drug for rare lung disease achieves 'home run' in mid-stage trial",
    "summary": "Insmed said on Tuesday thatits experimental drug significantly reduced blood pressure inthe lungs and improved exercise capacity in patients in amid-stage study, lifting its shares up as much as...",
    "url": "https://finnhub.io/api/news?id=eb6fe385570c216ba63c00123f76004d6c52dc80462fc56078b97cbc4746581d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749540749,
      "headline": "Insmed's drug for rare lung disease achieves 'home run' in mid-stage trial",
      "id": 135156757,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Insmed said on Tuesday thatits experimental drug significantly reduced blood pressure inthe lungs and improved exercise capacity in patients in amid-stage study, lifting its shares up as much as...",
      "url": "https://finnhub.io/api/news?id=eb6fe385570c216ba63c00123f76004d6c52dc80462fc56078b97cbc4746581d"
    }
  },
  {
    "ts": null,
    "headline": "Insmed's drug for rare lung disease meets main goal in mid-stage trial",
    "summary": "June 10 - Insmed said on Tuesday that its experimental drugsignificantly reduced blood pressure in the lungs and improvedexercise capacity in patients in a mid-stage study,...",
    "url": "https://finnhub.io/api/news?id=5657385adeba3e82e93183fd4ba8695900ec9d81a3a0e023a39e466908a5a056",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749540749,
      "headline": "Insmed's drug for rare lung disease meets main goal in mid-stage trial",
      "id": 135147785,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "June 10 - Insmed said on Tuesday that its experimental drugsignificantly reduced blood pressure in the lungs and improvedexercise capacity in patients in a mid-stage study,...",
      "url": "https://finnhub.io/api/news?id=5657385adeba3e82e93183fd4ba8695900ec9d81a3a0e023a39e466908a5a056"
    }
  }
]